With the nationwide COVID-19 vaccination effort well underway, many of Feinberg’s medical students have volunteered to administer vaccines to patients at Northwestern Medicine healthcare sites across Chicago.
Two Northwestern Medicine studies are improving the understanding of epigenetic mechanisms in cancer development and progression, and identifying novel cancer driver genes that may help identify patients who will benefit from immunotherapy.
A team of Northwestern Medicine investigators led by Rina Fox, PhD, MPH, received a Cancer and Aging Translational Bridge Award to investigate circadian disruption in lymphoma.
An FDA-approved monoclonal antibody drug used to treat advanced bladder cancer demonstrated poor efficacy in a recent clinical trial.
Diane B. Wayne, ’91 MD, and Mary McDermott, MD, ’92 GME, have been recognized by the Society of General Internal Medicine for their lifetime contributions to medical education and research.
Prolonged contact between the mitochondria and the lysosome causes aberrant distribution of mitochondria, contributing to neuronal dysfunction in Parkinson’s disease.
The Northwestern University Leadership Education Advancement Program (NU-LEAP) welcomed its inaugural class of Feinberg faculty graduates during a virtual ceremony on April 13.
Admitted students recently attended this year’s virtual Second Look, a month-long series of online informational sessions about the medical school’s curriculum and community and opportunities to speak with current students and faculty.
Northwestern Medicine investigators are advancing the understanding of two groups of transcription factors and their role in many neurodevelopmental diseases and cancers, which is essential for developing novel therapeutic approaches.
Northwestern Medicine investigators have discovered how a particular type of immune cell exerts a dual function in cancer cells that is contingent on tumor grade.